EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib

Anna Buder, Maximilian J. Hochmair, Ulrike Setinek, Robert Pirker, Martin Filipits

Article Options

Download Citation